New hope for pancreatic cancer: chemo combo shows promise in shrinking tumors before surgery

NCT ID NCT02676349

First seen Mar 29, 2026 · Last updated May 13, 2026 · Updated 9 times

Summary

This study tested two treatment plans for people with pancreatic cancer that is on the edge of being removable by surgery. 130 patients received either chemotherapy alone or chemotherapy plus radiation before surgery. The goal was to see which approach leads to a higher rate of clean surgical margins (no cancer left behind). The study is complete, and results help guide future treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHP Saint Grégoire

    Saint-Grégoire, France

  • CHU Reims

    Reims, France

  • Centre Eugène Marquis

    Rennes, France

  • Centre Oscar Lambret

    Lille, France

  • Chru Lille

    Lille, France

  • Chru Nancy

    Vandœuvre-lès-Nancy, France

  • Chru Tours

    Tours, France

  • Chu Colmar

    Colmar, France

  • Chu Nantes

    Nantes, France

  • Chu Rouen

    Rouen, France

  • Hôpital Beaujon

    Clichy, 92110, France

  • Hôpital Cochin (APHP)

    Paris, France

  • Hôpital Européen Marseille

    Marseille, France

  • Hôpital Haut-Lévêque

    Pessac, France

  • Hôpital Henri Mondor (APHP)

    Créteil, France

  • Hôpital La Timone

    Marseille, France

  • Hôpital Paul Brousse

    Villejuif, 94804, France

  • Infirmerie Protestante de Lyon

    Lyon, France

  • Institut Bergonié

    Bordeaux, France

  • Institut Mutualiste Montsouris

    Paris, France

  • Institut Paoli CALMETTES

    Marseille, France

  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, France

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, France

  • Institut du Cancer de Montpellier

    Montpellier, France

  • Pitié Salpêtrière (APHP)

    Paris, France

  • Polyclinique Bordeaux Nord

    Bordeaux, France

Conditions

Explore the condition pages connected to this study.